Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medterra Calm CBD Gummies
- Development stage
- Unknown
- Lead developer
- Medterra
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Medterra Calm CBD Gummies are a consumer wellness product designed to promote relaxation and manage everyday stress. The formulation combines 25mg of broad-spectrum cannabidiol (CBD) with 125mg of L-theanine. CBD is a non-psychoactive cannabinoid extracted from hemp that interacts with the body's endocannabinoid system to support natural relaxation and mental clarity. L-theanine is an amino acid naturally found in green tea leaves that is associated with reduced stress and improved focus without causing drowsiness. The product is marketed as a THC-free, vegan, and gluten-free gummy intended for oral use. As a nutraceutical product, it is positioned for general wellness rather than as a pharmaceutical treatment for clinical disorders.
- Brand names
- Medterra Calm CBD Gummies
- Other names
- Calm CBD GummiesMedterra Calm Gummies
02
Targets
TRPV1 (Transient receptor potential cation channel subfamily V member 1)FAAHPPARG (Peroxisome proliferator-activated receptor gamma)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))GPR55 (G protein-coupled receptor 55)CB2 (Cannabinoid receptor 2)
Beyond the preview
Go deeper on Medterra Calm CBD Gummies.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medterra Calm CBD Gummies.